Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Structural Biology and Molecular Modeling Market: By Tools, By Application, and Geography
Structural Biology and Molecular Modeling Market: By Tools, By Application, and Geography
Structural Biology And Molecular Modeling Market is estimated to be valued at US$ 7,891.2 million in 2022 and is poised to grow at a significant CAGR of 16.3% over 2023-2029. Structural biology investigates the molecular structure of biological macromolecules such as proteins and nucleic acids, providing essential insight into the biological mechanisms that sustain life. Technological advancements, such as virtual reality and software, have the potential to change the drug research industry. Protein is the primary focus of structural biologists due to its importance in the body. They investigate the functioning of molecules and how they respond to create new life. All drug design firms are working on modeling projects to better understand the structure of freshly developed medications so that they can bid on them. People's poor lifestyles these days contribute to an increase in chronic idiopathic constipation treatment illness instances. The growing senior population in wealthy nations raises the incidence of chronic illnesses such as diabetes and cancer. This structural biology and molecular modeling are useful in the medical and healthcare sectors since it aids in the discovery of cures for a variety of disorders. Increased investment in R&D by pharmaceutical companies will boost this industry since it will result in valuable discoveries that will provide solutions to many incurable diseases. The emergence of new diseases, such as coronavirus and Ebola, might potentially push this industry in the future. The government is working hard and promoting research and pharmaceutical companies to enhance medical quality. But, they are also imposing severe laws to govern the research and pharmaceutical companies, requiring them to follow the criteria so that in developing and producing better quality and outcomes, they do not jeopardies other things.
Structural Biology And Molecular Modeling Market Key Developments:
In July 2022, Cadence Design Systems Inc acquired Open Eye Scientific Software inc to leverage Cadence's computational software expertise in molecular modelling and simulation.
Study Period
2024-2030Base Year
2023CAGR
16.3%Largest Market
North AmericaFastest Growing Market
Asia Pacific
People's unhealthy lifestyles these days are leading to an increase in chronic illness cases, and the growth in the geriatric population in developed nations is also contributing to an increase in chronic disease cases such as diabetes, cancer, heart disease, and so on. This structural biology and molecular modeling is particularly valuable in the medical and healthcare sectors since it aids in the discovery of cures for various disorders. As a result, the rising prevalence of chronic illnesses as a result of an unhealthy lifestyle is driving this industry. Furthermore, increased R&D expenditure by pharmaceutical companies will fuel this market since it may result in productive discoveries that could provide solutions to many incurable diseases.
The global structural biology and molecular modeling market in North America held the highest share in 2022 and it is expected to grow at a significant rate in the coming years. Due to the most modern and improved infrastructure. This region also has a large pharmaceutical business that is investing in R&D to develop a better cure for the condition. This would fuel the market for structural biology and molecular modeling. Also, the major companies are working to improve R&D skills to provide a better solution for the illnesses that would drive this market in this area.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2022 |
US$ 7,891.2 million |
|
Market CAGR |
16.3% |
|
By Tools |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The global structural biology and molecular modeling market has been segmented based on tools, applications, and regions. The SaaS & standalone modeling segment held a substantial market share in 2020.
The North American region emerged as the largest market for structural biology and molecular modeling.
Increasing occurrence of chronic diseases is the key driving factor for the structural biology and molecular modelling market.
1. Executive Summary
2. Global Structural Biology and Molecular Modeling Introduction
2.1. Global Structural Biology and Molecular Modeling – Taxonomy
2.2. Global Structural Biology and Molecular Modeling –Definitions
2.2.1. Tools
2.2.2. Application
2.2.3. Region
3. Global Structural Biology and Molecular Modeling Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Structural Biology and Molecular Modeling Dynamic Factors - Impact Analysis
3.6. Impact of COVID-19 on The Market
3.7. Three Forecast Scenarios - Pessimistic, Conservative, and Opportunistic
3.8. Mapping Market Player’s Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations, and Mergers
4. Global Structural Biology and Molecular Modeling Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Structural Biology and Molecular Modeling Forecast, By Tools, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
5.1. SaaS and Standalone Modeling
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Visualization and Analysis
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Other Tools
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Structural Biology and Molecular Modeling Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.1. Drug Development
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Drug Discovery
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Other Applications
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Structural Biology and Molecular Modeling Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Structural Biology and Molecular Modeling - Opportunity Analysis Index, By Tools, Distribution Channel, End User, and Region, 2023 - 2029
8. North America Structural Biology and Molecular Modeling Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
8.1. Tools Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.1.1. SaaS and Standalone Modeling
8.1.2. Visualization and Analysis
8.1.3. Other Tools
8.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Drug Development
8.2.2. Drug Discovery
8.2.3. Other Applications
8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Structural Biology and Molecular Modeling - Opportunity Analysis Index, By Tools, Application and Country, 2023 - 2029
8.5. North America Structural Biology and Molecular Modeling Dynamics – Trends
9. Europe Structural Biology and Molecular Modeling Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
9.1. Tools Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.1.1. SaaS and Standalone Modeling
9.1.2. Visualization and Analysis
9.1.3. Other Tools
9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Drug Development
9.2.2. Drug Discovery
9.2.3. Other Applications
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Europe Structural Biology and Molecular Modeling - Opportunity Analysis Index, By Tools, Application and Country, 2023 - 2029
9.5. Europe Structural Biology and Molecular Modeling Dynamics – Trends
10. Asia-Pacific Structural Biology and Molecular Modeling Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
10.1. Tools Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.1.1. SaaS and Standalone Modeling
10.1.2. Visualization and Analysis
10.1.3. Other Tools
10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Drug Development
10.2.2. Drug Discovery
10.2.3. Other Applications
10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Rest of Asia-Pacific
10.4. Asia-Pacific Structural Biology and Molecular Modeling - Opportunity Analysis Index, By Tools, Application and Country, 2023 - 2029
10.5. Asia-Pacific Structural Biology and Molecular Modeling Dynamics – Trends
11. Latin America Structural Biology and Molecular Modeling Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
11.1. Tools Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.1.1. SaaS and Standalone Modeling
11.1.2. Visualization and Analysis
11.1.3. Other Tools
11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Drug Development
11.2.2. Drug Discovery
11.2.3. Other Applications
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Rest of Latin America
11.4. Latin America Structural Biology and Molecular Modeling - Opportunity Analysis Index, By Tools, Application and Country, 2023 - 2029
11.5. Latin America Structural Biology and Molecular Modeling Dynamics – Trends
12. Middle East and Africa Structural Biology and Molecular Modeling Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million)
12.1. Tools Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.1.1. SaaS and Standalone Modeling
12.1.2. Visualization and Analysis
12.1.3. Other Tools
12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Drug Development
12.2.2. Drug Discovery
12.2.3. Other Applications
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Saudi Arabia
12.3.2. GCC Countries
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Structural Biology and Molecular Modeling - Opportunity Analysis Index, By Tools, Application and Country, 2023 - 2029
12.5. MEA Structural Biology and Molecular Modeling Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Tools Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Acellera Ltd
13.2.2. Agile Molecule
13.2.3. Agilent Technologies Inc.
13.2.4. Biomax Informatics AG
13.2.5. Bruker Daltonics Inc.
13.2.6. Chemical Computing Group
13.2.7. Dassault Systemes
13.2.8. Illumina
13.2.9. ThermoFisher Scientific
13.2.10. CD BioSciences
13.2.11. Charles River Technologies
13.2.12. Horiba
14. Research Methodology
15. Key Assumptions and Acronyms
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.